CARsgen Appoints Dr. Hong MA as Senior Vice President of Clinical Development
August 27, 2018 — 21:00 CST
This Data Is Locked!
This area is available only to Subscribers.
SHANGHAI, Aug. 27, 2018 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, announced appointment of Dr.... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
